NO20074741L - Fremgangsmate for fremstilling av farmakokinetisk forbedrede forbindelser omfattende funksjonelle rester eller grupper, og farmasoytiske preparater omfattende angitte forbindelser - Google Patents

Fremgangsmate for fremstilling av farmakokinetisk forbedrede forbindelser omfattende funksjonelle rester eller grupper, og farmasoytiske preparater omfattende angitte forbindelser

Info

Publication number
NO20074741L
NO20074741L NO20074741A NO20074741A NO20074741L NO 20074741 L NO20074741 L NO 20074741L NO 20074741 A NO20074741 A NO 20074741A NO 20074741 A NO20074741 A NO 20074741A NO 20074741 L NO20074741 L NO 20074741L
Authority
NO
Norway
Prior art keywords
compounds
pharmaceutical compositions
groups
preparation
functional residues
Prior art date
Application number
NO20074741A
Other languages
English (en)
Norwegian (no)
Inventor
David Duffy
Michael Grogan
Steven Kates
Emanuele Ostuni
Olivier Schueller
Paul Sweetnam
Stewart Campbell
Original Assignee
Surface Logix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Surface Logix Inc filed Critical Surface Logix Inc
Publication of NO20074741L publication Critical patent/NO20074741L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20074741A 2005-02-18 2007-09-17 Fremgangsmate for fremstilling av farmakokinetisk forbedrede forbindelser omfattende funksjonelle rester eller grupper, og farmasoytiske preparater omfattende angitte forbindelser NO20074741L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65451905P 2005-02-18 2005-02-18
PCT/US2006/006047 WO2006089275A2 (en) 2005-02-18 2006-02-21 Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds

Publications (1)

Publication Number Publication Date
NO20074741L true NO20074741L (no) 2007-11-14

Family

ID=36917158

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074741A NO20074741L (no) 2005-02-18 2007-09-17 Fremgangsmate for fremstilling av farmakokinetisk forbedrede forbindelser omfattende funksjonelle rester eller grupper, og farmasoytiske preparater omfattende angitte forbindelser

Country Status (19)

Country Link
US (1) US20110172422A1 (ja)
EP (1) EP1848437A4 (ja)
JP (1) JP2008530246A (ja)
KR (1) KR20080015391A (ja)
CN (1) CN101287468A (ja)
AU (1) AU2006213984A1 (ja)
BR (1) BRPI0608356A2 (ja)
CA (1) CA2598270A1 (ja)
CR (1) CR9383A (ja)
EA (1) EA200701752A1 (ja)
IL (1) IL185347A0 (ja)
MX (1) MX2007010142A (ja)
NI (1) NI200700211A (ja)
NO (1) NO20074741L (ja)
NZ (1) NZ560962A (ja)
SG (1) SG174829A1 (ja)
UA (1) UA95604C2 (ja)
WO (1) WO2006089275A2 (ja)
ZA (1) ZA200707506B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR9465A (es) * 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente
US20100324037A1 (en) * 2006-08-24 2010-12-23 Surface Logix, Inc. Pharmacokinetically improved compounds
EP3360962A1 (en) * 2017-02-14 2018-08-15 Technische Universität Dortmund Synthesis of dna-encoded libraries by micellar catalysis

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH445129A (fr) * 1964-04-29 1967-10-15 Nestle Sa Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé
US3459731A (en) * 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
US3426011A (en) * 1967-02-13 1969-02-04 Corn Products Co Cyclodextrins with anionic properties
US3453257A (en) * 1967-02-13 1969-07-01 Corn Products Co Cyclodextrin with cationic properties
US3453259A (en) * 1967-03-22 1969-07-01 Corn Products Co Cyclodextrin polyol ethers and their oxidation products
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US4737323A (en) * 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5359115A (en) * 1992-03-26 1994-10-25 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5480971A (en) * 1993-06-17 1996-01-02 Houghten Pharmaceuticals, Inc. Peralkylated oligopeptide mixtures
US5440016A (en) * 1993-06-18 1995-08-08 Torrey Pines Institute For Molecular Studies Peptides of the formula (KFmoc) ZZZ and their uses
US5362899A (en) * 1993-09-09 1994-11-08 Affymax Technologies, N.V. Chiral synthesis of alpha-aminophosponic acids
HU230154B1 (hu) * 1997-11-12 2015-09-28 Bayer Intellectual Property Gmbh Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására
US5958886A (en) * 1998-01-13 1999-09-28 Sigma-Tau Pharmaceuticals, Inc. Carnitine-containing peptides and a method for using the same
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
KR100353014B1 (ko) * 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
CA2323008C (en) * 1999-10-11 2005-07-12 Pfizer Inc. Pharmaceutically active compounds
JP2003519151A (ja) * 1999-12-24 2003-06-17 バイエル アクチェンゲゼルシャフト トリアゾロトリアジノンおよびそれらの使用
CN1434825A (zh) * 1999-12-24 2003-08-06 拜尔公司 咪唑并[1,3,5]三嗪酮及其应用
US6794387B2 (en) * 2001-03-28 2004-09-21 Pfizer Inc. Pharmaceutically active compounds
KR20080016531A (ko) * 2005-02-18 2008-02-21 서피스 로직스, 인크. 약동학적으로 개선된 화합물

Also Published As

Publication number Publication date
WO2006089275A2 (en) 2006-08-24
EA200701752A1 (ru) 2008-04-28
CA2598270A1 (en) 2006-08-24
SG174829A1 (en) 2011-10-28
UA95604C2 (ru) 2011-08-25
WO2006089275A3 (en) 2006-12-21
AU2006213984A1 (en) 2006-08-24
CR9383A (es) 2008-06-19
MX2007010142A (es) 2007-12-07
IL185347A0 (en) 2008-02-09
US20110172422A1 (en) 2011-07-14
KR20080015391A (ko) 2008-02-19
NZ560962A (en) 2011-12-22
JP2008530246A (ja) 2008-08-07
EP1848437A4 (en) 2012-04-25
ZA200707506B (en) 2009-08-26
BRPI0608356A2 (pt) 2009-12-29
CN101287468A (zh) 2008-10-15
EP1848437A2 (en) 2007-10-31
NI200700211A (es) 2008-07-24

Similar Documents

Publication Publication Date Title
WO2007022070A3 (en) Modified fc molecules
WO2004035170A3 (en) Composition for separating molecules
MX2009006199A (es) Formulacion parenteral de anticuerpos abeta.
WO2009034119A8 (en) Improved derivatives of amylin
NO20091563L (no) Proteaseresistente insulinanaloger
WO2006091457A3 (en) Ionic liquids derived from peracid anions
WO2007112264A3 (en) Cleavable linkers for polynucleotides
WO2009137721A3 (en) Lysosomal targeting peptides and uses thereof
WO2005107491A3 (en) Multi-lectin affinity chromatography and uses thereof
WO2007062190A3 (en) Chemical compounds
NO20064034L (no) Makrolider og fremgangsmater for a fremstille disse
WO2008097342A3 (en) Compositions and methods for isolation of biological molecules
WO2007038058A3 (en) Amino-aza-adamantane derivatives and methods of use
WO2007103485A3 (en) Small rna purification
WO2008059370A3 (en) Substituted bicyclocarboxyamide compounds
WO2008149345A3 (en) Tri-aryl compounds and compositions comprising the same
WO2008050199A8 (en) Substituted phenylmethyl bicyclocarboxyamide compounds
WO2008118626A3 (en) Inhibitors of jnk and methods for identifying inhibitors of jnk
WO2006032893A3 (en) Trityl derivatives for enhancing mass spectrometry
WO2006087163A3 (en) Novel in vitro methods for studying receptors recognizing volatile compounds
WO2006075139A3 (en) Novel process for the preparation of substituted indoles
WO2008147812A3 (en) 4' substituted compounds having 5-ht6 receptor affinity
WO2007016029A3 (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
WO2005097203A3 (en) Serum protein conjugates of ion channel modulating compounds and uses thereof
WO2009003952A3 (en) Column and method for preparing a biological sample for protein profiling

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application